Living related donor liver transplantation for primary sclerosing cholangitis with hepatocellular carcinoma and Crohn's disease: A case report
β Scribed by H. Oya; Y. Sato; S. Yamamoto; T. Takeishi; T. Kobayashi; K. Hatakeyama
- Book ID
- 116930159
- Publisher
- Elsevier Science
- Year
- 2004
- Tongue
- English
- Weight
- 45 KB
- Volume
- 36
- Category
- Article
- ISSN
- 0041-1345
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
Liver transplantation (LT) is the treatment of choice for early hepatocellular carcinoma (HCC) in patients with end-stage liver disease but is limited by the availability of donor organs. Living donor liver transplantation (LDLT) represents an alternative therapeutic option for patients with disease
Living donor liver transplantation (LDLT) has evolved to represent an important surgical strategy for patients with hepatocellular carcinoma (HCC). However, due to disadvantages, including donor risks and higher rates of perioperative complications, LDLT has been considered as a second-line treatmen